 | • レポートコード：GIR-2104Z07255 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒト胚性幹細胞（HESC）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒト胚性幹細胞（HESC）の種類別市場規模（全能性幹細胞、多能性幹細胞、単能性幹細胞）、用途別市場規模（研究、臨床試験、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒト胚性幹細胞（HESC）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：ESI BIO、Thermo Fisher、BioTime、MilliporeSigma (Merck)、BD Biosciences、Astellas Institute of Regenerative Medicine、Asterias Biotherapeutics、PerkinElmer、Takara Bio、Fujifilm Cellular Dynamics、Reliance Life Sciences、R&D Systems (Biotrchne)、STEMCELL Technologies、TATAA Biocenter、UK Stem Cell Bank、Viacyte, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：全能性幹細胞、多能性幹細胞、単能性幹細胞 ・用途別分析2016年-2026年：研究、臨床試験、その他 ・ヒト胚性幹細胞（HESC）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒト胚性幹細胞（HESC）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト胚性幹細胞（HESC）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト胚性幹細胞（HESC）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒト胚性幹細胞（HESC）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Embryonic Stem Cells (HESC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Human Embryonic Stem Cells (HESC) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Human Embryonic Stem Cells (HESC) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Human Embryonic Stem Cells (HESC) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Market segment by Application can be divided into
Research
Clinical Trials
Others
The key market players for global Human Embryonic Stem Cells (HESC) market are listed below:
ESI BIO
Thermo Fisher
BioTime
MilliporeSigma (Merck)
BD Biosciences
Astellas Institute of Regenerative Medicine
Asterias Biotherapeutics
PerkinElmer
Takara Bio
Fujifilm Cellular Dynamics
Reliance Life Sciences
R&D Systems (Biotrchne)
STEMCELL Technologies
TATAA Biocenter
UK Stem Cell Bank
Viacyte, Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Human Embryonic Stem Cells (HESC) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Embryonic Stem Cells (HESC) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Totipotent Stem Cells
1.2.3 Pluripotent Stem Cells
1.2.4 Unipotent Stem Cells
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Embryonic Stem Cells (HESC) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Research
1.3.3 Clinical Trials
1.3.4 Others
1.4 Global Human Embryonic Stem Cells (HESC) Market Size & Forecast
1.4.1 Global Human Embryonic Stem Cells (HESC) Sales in Value (2016-2026))
1.4.2 Global Human Embryonic Stem Cells (HESC) Sales in Volume (2016-2026)
1.4.3 Global Human Embryonic Stem Cells (HESC) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Human Embryonic Stem Cells (HESC) Production Capacity Analysis
1.5.1 Global Human Embryonic Stem Cells (HESC) Total Production Capacity (2016-2026)
1.5.2 Global Human Embryonic Stem Cells (HESC) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Embryonic Stem Cells (HESC) Market Drivers
1.6.2 Human Embryonic Stem Cells (HESC) Market Restraints
1.6.3 Human Embryonic Stem Cells (HESC) Trends Analysis
2 Manufacturers Profiles
2.1 ESI BIO
2.1.1 ESI BIO Details
2.1.2 ESI BIO Major Business
2.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Product and Services
2.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Product and Services
2.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 BioTime
2.3.1 BioTime Details
2.3.2 BioTime Major Business
2.3.3 BioTime Human Embryonic Stem Cells (HESC) Product and Services
2.3.4 BioTime Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 MilliporeSigma (Merck)
2.4.1 MilliporeSigma (Merck) Details
2.4.2 MilliporeSigma (Merck) Major Business
2.4.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product and Services
2.4.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 BD Biosciences
2.5.1 BD Biosciences Details
2.5.2 BD Biosciences Major Business
2.5.3 BD Biosciences Human Embryonic Stem Cells (HESC) Product and Services
2.5.4 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Astellas Institute of Regenerative Medicine
2.6.1 Astellas Institute of Regenerative Medicine Details
2.6.2 Astellas Institute of Regenerative Medicine Major Business
2.6.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product and Services
2.6.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Asterias Biotherapeutics
2.7.1 Asterias Biotherapeutics Details
2.7.2 Asterias Biotherapeutics Major Business
2.7.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product and Services
2.7.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 PerkinElmer
2.8.1 PerkinElmer Details
2.8.2 PerkinElmer Major Business
2.8.3 PerkinElmer Human Embryonic Stem Cells (HESC) Product and Services
2.8.4 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Takara Bio
2.9.1 Takara Bio Details
2.9.2 Takara Bio Major Business
2.9.3 Takara Bio Human Embryonic Stem Cells (HESC) Product and Services
2.9.4 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Fujifilm Cellular Dynamics
2.10.1 Fujifilm Cellular Dynamics Details
2.10.2 Fujifilm Cellular Dynamics Major Business
2.10.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product and Services
2.10.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Reliance Life Sciences
2.11.1 Reliance Life Sciences Details
2.11.2 Reliance Life Sciences Major Business
2.11.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product and Services
2.11.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 R&D Systems (Biotrchne)
2.12.1 R&D Systems (Biotrchne) Details
2.12.2 R&D Systems (Biotrchne) Major Business
2.12.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product and Services
2.12.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 STEMCELL Technologies
2.13.1 STEMCELL Technologies Details
2.13.2 STEMCELL Technologies Major Business
2.13.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product and Services
2.13.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 TATAA Biocenter
2.14.1 TATAA Biocenter Details
2.14.2 TATAA Biocenter Major Business
2.14.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product and Services
2.14.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 UK Stem Cell Bank
2.15.1 UK Stem Cell Bank Details
2.15.2 UK Stem Cell Bank Major Business
2.15.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product and Services
2.15.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Viacyte, Inc.
2.16.1 Viacyte, Inc. Details
2.16.2 Viacyte, Inc. Major Business
2.16.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product and Services
2.16.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Human Embryonic Stem Cells (HESC) Sales by Manufacturer
3.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Embryonic Stem Cells (HESC)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Embryonic Stem Cells (HESC) Manufacturer Market Share
3.4.2 Top 6 Human Embryonic Stem Cells (HESC) Manufacturer Market Share
3.5 Global Human Embryonic Stem Cells (HESC) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Embryonic Stem Cells (HESC) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Embryonic Stem Cells (HESC) Market Size by Region
4.1.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Region (2016-2026)
4.1.2 Global Human Embryonic Stem Cells (HESC) Revenue by Region (2016-2026)
4.2 North America Human Embryonic Stem Cells (HESC) Revenue (2016-2026)
4.3 Europe Human Embryonic Stem Cells (HESC) Revenue (2016-2026)
4.4 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue (2016-2026)
4.5 South America Human Embryonic Stem Cells (HESC) Revenue (2016-2026)
4.6 Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Type (2016-2026)
5.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2016-2026)
5.3 Global Human Embryonic Stem Cells (HESC) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Application (2016-2026)
6.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2016-2026)
6.3 Global Human Embryonic Stem Cells (HESC) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Embryonic Stem Cells (HESC) Sales by Type (2016-2026)
7.2 North America Human Embryonic Stem Cells (HESC) Sales by Application (2016-2026)
7.3 North America Human Embryonic Stem Cells (HESC) Market Size by Country
7.3.1 North America Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2016-2026)
7.3.2 North America Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Embryonic Stem Cells (HESC) Sales by Type (2016-2026)
8.2 Europe Human Embryonic Stem Cells (HESC) Sales by Application (2016-2026)
8.3 Europe Human Embryonic Stem Cells (HESC) Market Size by Country
8.3.1 Europe Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Type (2016-2026)
9.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Application (2016-2026)
9.3 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Size by Region
9.3.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Embryonic Stem Cells (HESC) Sales by Type (2016-2026)
10.2 South America Human Embryonic Stem Cells (HESC) Sales by Application (2016-2026)
10.3 South America Human Embryonic Stem Cells (HESC) Market Size by Country
10.3.1 South America Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2016-2026)
10.3.2 South America Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Type (2016-2026)
11.2 Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Application (2016-2026)
11.3 Middle East & Africa Human Embryonic Stem Cells (HESC) Market Size by Country
11.3.1 Middle East & Africa Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Embryonic Stem Cells (HESC) Typical Distributors
12.3 Human Embryonic Stem Cells (HESC) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Human Embryonic Stem Cells (HESC) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Embryonic Stem Cells (HESC) Revenue by Application, (USD Million), 2021-2026
Table 3. ESI BIO Basic Information, Manufacturing Base and Competitors
Table 4. ESI BIO Major Business
Table 5. ESI BIO Human Embryonic Stem Cells (HESC) Product and Services
Table 6. ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 8. Thermo Fisher Major Business
Table 9. Thermo Fisher Human Embryonic Stem Cells (HESC) Product and Services
Table 10. Thermo Fisher Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. BioTime Basic Information, Manufacturing Base and Competitors
Table 12. BioTime Major Business
Table 13. BioTime Human Embryonic Stem Cells (HESC) Product and Services
Table 14. BioTime Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. MilliporeSigma (Merck) Basic Information, Manufacturing Base and Competitors
Table 16. MilliporeSigma (Merck) Major Business
Table 17. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product and Services
Table 18. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. BD Biosciences Basic Information, Manufacturing Base and Competitors
Table 20. BD Biosciences Major Business
Table 21. BD Biosciences Human Embryonic Stem Cells (HESC) Product and Services
Table 22. BD Biosciences Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Astellas Institute of Regenerative Medicine Basic Information, Manufacturing Base and Competitors
Table 24. Astellas Institute of Regenerative Medicine Major Business
Table 25. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product and Services
Table 26. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Asterias Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Asterias Biotherapeutics Major Business
Table 29. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product and Services
Table 30. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. PerkinElmer Basic Information, Manufacturing Base and Competitors
Table 32. PerkinElmer Major Business
Table 33. PerkinElmer Human Embryonic Stem Cells (HESC) Product and Services
Table 34. PerkinElmer Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 36. Takara Bio Major Business
Table 37. Takara Bio Human Embryonic Stem Cells (HESC) Product and Services
Table 38. Takara Bio Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Fujifilm Cellular Dynamics Basic Information, Manufacturing Base and Competitors
Table 40. Fujifilm Cellular Dynamics Major Business
Table 41. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product and Services
Table 42. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Reliance Life Sciences Major Business
Table 45. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product and Services
Table 46. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. R&D Systems (Biotrchne) Basic Information, Manufacturing Base and Competitors
Table 48. R&D Systems (Biotrchne) Major Business
Table 49. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product and Services
Table 50. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. STEMCELL Technologies Basic Information, Manufacturing Base and Competitors
Table 52. STEMCELL Technologies Major Business
Table 53. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product and Services
Table 54. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. TATAA Biocenter Basic Information, Manufacturing Base and Competitors
Table 56. TATAA Biocenter Major Business
Table 57. TATAA Biocenter Human Embryonic Stem Cells (HESC) Product and Services
Table 58. TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. UK Stem Cell Bank Basic Information, Manufacturing Base and Competitors
Table 60. UK Stem Cell Bank Major Business
Table 61. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product and Services
Table 62. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Viacyte, Inc. Basic Information, Manufacturing Base and Competitors
Table 64. Viacyte, Inc. Major Business
Table 65. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product and Services
Table 66. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Human Embryonic Stem Cells (HESC) Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Human Embryonic Stem Cells (HESC), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Human Embryonic Stem Cells (HESC) Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Human Embryonic Stem Cells (HESC) Production Site of Key Manufacturer
Table 72. Global Human Embryonic Stem Cells (HESC) Sales by Region (2016-2021e) & (K Units)
Table 73. Global Human Embryonic Stem Cells (HESC) Sales by Region (2021-2026) & (K Units)
Table 74. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Human Embryonic Stem Cells (HESC) Sales by Type (2016-2021e) & (K Units)
Table 77. Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units)
Table 78. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Human Embryonic Stem Cells (HESC) Price by Type (2016-2021e) & (USD/Unit)
Table 81. Global Human Embryonic Stem Cells (HESC) Price by Type (2021-2026) & (USD/Unit)
Table 82. Global Human Embryonic Stem Cells (HESC) Sales by Application (2016-2021e) & (K Units)
Table 83. Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units)
Table 84. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Human Embryonic Stem Cells (HESC) Price by Application (2016-2021e) & (USD/Unit)
Table 87. Global Human Embryonic Stem Cells (HESC) Price by Application (2021-2026) & (USD/Unit)
Table 88. North America Human Embryonic Stem Cells (HESC) Sales by Country (2016-2021e) & (K Units)
Table 89. North America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units)
Table 90. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Human Embryonic Stem Cells (HESC) Sales by Type (2016-2021e) & (K Units)
Table 93. North America Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units)
Table 94. North America Human Embryonic Stem Cells (HESC) Sales by Application (2016-2021e) & (K Units)
Table 95. North America Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units)
Table 96. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2016-2021e) & (K Units)
Table 97. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units)
Table 98. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Human Embryonic Stem Cells (HESC) Sales by Type (2016-2021e) & (K Units)
Table 101. Europe Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units)
Table 102. Europe Human Embryonic Stem Cells (HESC) Sales by Application (2016-2021e) & (K Units)
Table 103. Europe Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units)
Table 104. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Region (2016-2021e) & (K Units)
Table 105. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Region (2021-2026) & (K Units)
Table 106. Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Type (2016-2021e) & (K Units)
Table 109. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units)
Table 110. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Application (2016-2021e) & (K Units)
Table 111. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units)
Table 112. South America Human Embryonic Stem Cells (HESC) Sales by Country (2016-2021e) & (K Units)
Table 113. South America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units)
Table 114. South America Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Human Embryonic Stem Cells (HESC) Sales by Type (2016-2021e) & (K Units)
Table 117. South America Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units)
Table 118. South America Human Embryonic Stem Cells (HESC) Sales by Application (2016-2021e) & (K Units)
Table 119. South America Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units)
Table 120. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Country (2016-2021e) & (K Units)
Table 121. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units)
Table 122. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Type (2016-2021e) & (K Units)
Table 125. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units)
Table 126. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Application (2016-2021e) & (K Units)
Table 127. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Human Embryonic Stem Cells (HESC) Typical Distributors
Table 131. Human Embryonic Stem Cells (HESC) Typical Customers
List of Figures
Figure 1. Human Embryonic Stem Cells (HESC) Picture
Figure 2. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type in 2020
Figure 3. Totipotent Stem Cells
Figure 4. Pluripotent Stem Cells
Figure 5. Unipotent Stem Cells
Figure 6. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application in 2020
Figure 7. Research
Figure 8. Clinical Trials
Figure 9. Others
Figure 10. Global Human Embryonic Stem Cells (HESC) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Human Embryonic Stem Cells (HESC) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Human Embryonic Stem Cells (HESC) Sales (2016-2026) & (K Units)
Figure 32. Global Human Embryonic Stem Cells (HESC) Production Capacity (2016-2026) & (K Units)
Figure 33. Global Human Embryonic Stem Cells (HESC) Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Human Embryonic Stem Cells (HESC) Market Drivers
Figure 35. Human Embryonic Stem Cells (HESC) Market Restraints
Figure 36. Human Embryonic Stem Cells (HESC) Market Trends
Figure 37. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturer in 2020
Figure 38. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Manufacturer in 2020
Figure 39. Human Embryonic Stem Cells (HESC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Human Embryonic Stem Cells (HESC) Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Human Embryonic Stem Cells (HESC) Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2016-2026)
Figure 43. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2016-2026)
Figure 44. North America Human Embryonic Stem Cells (HESC) Revenue (2016-2026) & (USD Million)
Figure 45. Europe Human Embryonic Stem Cells (HESC) Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue (2016-2026) & (USD Million)
Figure 47. South America Human Embryonic Stem Cells (HESC) Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue (2016-2026) & (USD Million)
Figure 49. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2016-2026)
Figure 50. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2016-2026)
Figure 51. Global Human Embryonic Stem Cells (HESC) Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2016-2026)
Figure 53. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2016-2026)
Figure 54. Global Human Embryonic Stem Cells (HESC) Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2016-2026)
Figure 56. North America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2016-2026)
Figure 57. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2016-2026)
Figure 58. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2016-2026)
Figure 59. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2016-2026)
Figure 60. Europe Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2016-2026)
Figure 61. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2016-2026)
Figure 62. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2016-2026)
Figure 67. South America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2016-2026)
Figure 68. South America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2016-2026)
Figure 69. South America Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2016-2026)
Figure 70. South America Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のヒト胚性幹細胞アッセイ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Embryonic Stem Cell Assay Market The global Human Embryonic Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界の上皮幹細胞市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Epithelial Stem Cells Market The global Epithelial Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界のがん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. Over the past few years, stem cells are being successf…
- 世界の臍帯血幹細胞市場 2021：企業別、地域別、種類・用途別 The Cord Blood Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…